Thought Leader: Michael Fronstin, General Manager, Health Outcomes, Forecasting and Epidemiology, Kantar Health
In this episode, Mr. Fronstin illustrates the size and scope of the pain market, addresses current unmet needs, outlines promising new Mechanisms of Action, and covers the implications for the pharma industry.
 |
| Michael Fronstin |
Download transcript of podcast
White Paper: The Pain Market and the Promise of New Mechanisms of Action
This white paper explores the current drug development landscape of the pain market and the most promising mechanisms of action in development. It identifies the pain conditions new drugs most commonly targeted for development focus on. Lastly, it covers the commercial implications for manufacturers.
Download white paper
.jpg "Kantar Health White Paper")
Posts
